Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 21Uterine Cervical Neoplasms 15Esophageal Neoplasms 3Endometrial Neoplasms 3Breast Neoplasms 3Vaginal Neoplasms 2Rhabdomyosarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Melanoma 2Uveal Melanoma 1Uterine Neoplasms 1Sarcoma 1Retinoblastoma 1Recurrent Head and Neck Carcinoma 1Prostatic Diseases 1Neuroectodermal Tumors, Primitive, Peripheral 1Metastatic Malignant Female Reproductive System Neoplasm 1Lung Neoplasms 1Locally Advanced Cervical Adenocarcinoma 1Gynecologic Cancer 1Esophageal Squamous Cell Carcinoma 1Endometrial Clear Cell Adenocarcinoma 1Desmoplastic Small Round Cell Tumor 1Cervical Adenocarcinoma 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

Paclitaxel 6pembrolizumab 3Cisplatin 3Carboplatin 3Biopsy 3adavosertib 2Trastuzumab 2Magnetic Resonance Spectroscopy 2Fulvestrant 2Doxorubicin 2ulixertinib 1tucatinib 1trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1trametinib 1selinexor 1sapanisertib 1sacituzumab govitecan 1relugolix 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1niraparib 1larotrectinib 1ipatasertib 1erdafitinib 1dostarlimab 1dehydroftorafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Neoplasms × Brachytherapy × 1 year × Clear all
NCT06331468 2025-12-26

Hypofractionated Radiochemotherapy

University of Kentucky

Phase 2 Recruiting
20 enrolled
Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡